Back
AngioDynamics Vs. Perspective Therapeutics Industry Stock Comparison
Buy
63
ANGO
AngioDynamics
Last Price:
6.42
Seasonality Move:
4.98%
Buy
61
CATX
Perspective Therapeutics
Last Price:
1.54
Seasonality Move:
2.36%
Buy
63
AngioDynamics (ANGO)
is a Buy
Is AngioDynamics a Buy, Sell or Hold?
- The current AngioDynamics [ANGO] share price is $6.42. The Score for ANGO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- ANGO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.53. The Score for CATX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ANGO Stock Price Chart
What is AngioDynamics's stock price today?
-
The AngioDynamics share price today is $6.42
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANGO is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.53
The current trend is moderately bearish and CATX is experiencing slight buying pressure.
ANGO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 58.73 | Buy |
| Chaikin Money Flow: | 279202 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.89 - 6.33) | Buy |
| Bollinger Bands (100): | (5.52 - 6.76) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 44.05 | Sell |
| Chaikin Money Flow: | 1336950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.51 - 1.77) | Sell |
| Bollinger Bands (100): | (0.65 - 1.51) | Buy |
ANGO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.16 | Buy |
| 20-day SMA: | 6.06 | Buy |
| 50-day SMA: | 6 | Buy |
| 200-day SMA: | 6.7 | Sell |
| 8-day EMA: | 6.21 | Buy |
| 20-day EMA: | 6.14 | Buy |
| 50-day EMA: | 6.1 | Buy |
| 200-day EMA: | 7.17 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.72 | Sell |
| 20-day SMA: | 1.69 | Sell |
| 50-day SMA: | 1.45 | Buy |
| 200-day SMA: | 0.7 | Buy |
| 8-day EMA: | 1.67 | Sell |
| 20-day EMA: | 1.65 | Sell |
| 50-day EMA: | 1.46 | Buy |
| 200-day EMA: | 0.9 | Buy |
AngioDynamics Earnings Growth & ANGO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.48 per share, and an increase next year of $0.04 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AngioDynamics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||